KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$89000.0.

  • Xenon Pharmaceuticals' Other Non Operating Income fell 13755.27% to -$89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $166000.0, marking a year-over-year decrease of 4876.54%. This contributed to the annual value of -$1.1 million for FY2024, which is 63467.34% down from last year.
  • According to the latest figures from Q3 2025, Xenon Pharmaceuticals' Other Non Operating Income is -$89000.0, which was down 13755.27% from $1.7 million recorded in Q2 2025.
  • In the past 5 years, Xenon Pharmaceuticals' Other Non Operating Income registered a high of $1.9 million during Q4 2021, and its lowest value of -$2.4 million during Q3 2022.
  • Its 5-year average for Other Non Operating Income is $48473.7, with a median of $117000.0 in 2021.
  • In the last 5 years, Xenon Pharmaceuticals' Other Non Operating Income tumbled by 176015.62% in 2022 and then skyrocketed by 1688000.0% in 2025.
  • Xenon Pharmaceuticals' Other Non Operating Income (Quarter) stood at $1.9 million in 2021, then tumbled by 68.13% to $602000.0 in 2022, then plummeted by 114.95% to -$90000.0 in 2023, then tumbled by 1542.22% to -$1.5 million in 2024, then soared by 93.98% to -$89000.0 in 2025.
  • Its Other Non Operating Income stands at -$89000.0 for Q3 2025, versus $1.7 million for Q2 2025 and $35000.0 for Q1 2025.